Skip to main content

ACoP 2024 Main banner

Conference Program

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Title

Browse by Poster Title

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#

C
M-101
Cardiovascular Model Parameterization of Digital Twins for Acute Care Drug Delivery: An Iterative Bayesian Approach

Favorite
W-134
Causal directed acyclic graph (DAG) application in exposure-response analyses

Favorite
W-063
Cell-line Specific Network Modeling to Assess Differential Signal Transduction of Oxaliplatin-based Drug Combinations for Colorectal Cancer

Favorite
T-094
Cellular and Humoral Semi-mechanistic Immune Response Models of a Vaccine Candidate for Respiratory Syncytial Virus Infection

Favorite
M-093
Challenges in curating Real World Data for modeling: A Bronchopulmonary Dysplasia case study

Favorite
W-091
Characterization of the Effect of Biofilm Formation on the Antimicrobial Activity of Tigecycline against M. abscessus using a Hollow Fiber Infection Model and Pharmacokinetic/Pharmacodynamic Modeling

Favorite
W-079
Characterizing Pharmacokinetics Effects on Measures of Overall Drug Exposure during Pregnancy

Favorite
W-045
Clinical Trial Simulation to Assess Sample Size and Power For Detecting Differences in Pharmacokinetic Exposure Metrics

Favorite
M-009
Combined multi-analyte population PK modeling of ABBV-400, a novel c-Met targeting ADC

Favorite
W-109
Comparative Analysis of Minimal Physiologically Based Pharmacokinetic (mPBPK) and Traditional Pharmacokinetic (PK) Models in the Context of Quantitative Systems Pharmacology (QSP) for T-cell Engagers

Favorite
W-064
Comparative evaluation of different vancomycin population pharmacokinetic models to predict Bayesian-estimated vancomycin AUC in Korean patients

Favorite
W-106
Comparing Predicted Serotype-specific Vaccine Effectiveness of Pneumococcal Conjugate Vaccines V114 and PCV20 in Children using a novel model-based meta-analysis approach

Favorite
T-022
Comparing the Efficacy of Various Insulin Types: A Pharmacokinetic and Pharmacodynamic Modeling Study in Healthy Volunteers

Favorite
W-080
Comparison of common methodologies for accounting for IIV for oral bioavailability (F) in the absence of intravenous data

Favorite
W-087
Comparison of empirical and physiologically-based modeling approaches to explore mechanisms of drug-drug interaction between abemaciclib and olaparib in a small cohort of patients with ovarian cancer

Favorite
T-108
Comparison of NONMEM and AI-Based Approaches for Population Pharmacokinetic Simulations to Support Model-Informed Drug Development

Favorite
T-031
Comparison of Sensitivity Analysis Methods in the Context of a QSP Model for Gout

Favorite
T-107
Comprehensive Human Quantitative Systems Pharmacology Models for Immuno-Oncology: Enhancing Decision-Making on Target Indications and Combination Strategies for New Drug Development

Favorite
W-070
Concentration-QTc Analysis of PF-07220060 in Patients with Advanced Solid Tumors

Favorite
W-055
Confounding Impact of Event-Driven Exposure Phenomenon on Summary Exposure Metrics in Time-to-Event Exposure Response Analyses

Favorite
W-114
Consideration of Study design aspects in the creation of virtual populations for organ impairment studies: One size may not fit all

Favorite
M-012
Considerations for Industry—Preparing for the FDA Model-Informed Drug Development (MIDD) Paired Meeting Program

Favorite
W-099
Constructing a virtual control arm and evaluating operating characteristics using TGI metrics to support go/no-go decisions for single-arm Phase Ib/II combination studies

Favorite
T-023
Cost-effectiveness of paliperidone palmitate long-acting injectables for the treatment of schizophrenic patients: a joint pharmacometric/pharmacoeconomic approach

Favorite
M-005
Coupling A Quantitative Systems Pharmacology Model With A Simple Statistical Layer To Predict Asthma Exacerbation Rate Reduction From Allergen Challenge Results

Favorite
M-127
Creating Cell-specific Computational Models of Stem Cell-derived Cardiomyocytes Using Optical Experiments

Favorite
M-111
Cystatin C complements but does not exceed serum creatinine as a renal function marker: evidence from vancomycin pharmacokinetic model performance in a clinical context

Favorite